Qingdao Baheal Medical INC.

Equities

301015

CNE100004LR8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-05-22 EDT 5-day change 1st Jan Change
32.42 CNY -1.94% Intraday chart for Qingdao Baheal Medical INC. -1.31% -9.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain A Shares of Qingdao Baheal Medical INC. are subject to a Lock-Up Agreement Ending on 1-JUL-2023. CI
Qingdao Baheal Medical Inc. Approves Cash Dividend for the Year of 2022, Payable on 25 May 2023 CI
Qingdao Baheal Medical INC. Announces Final Cash Dividend Proposal for 2022 CI
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Qingdao Baheal Medical INC.(XSEC:301015) added to S&P Global BMI Index CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Qingdao Baheal Medical Inc. Announces Management Appointments CI
Sinohealth Raises $43 Million in Hong Kong IPO MT
Certain A Shares of Qingdao Baheal Medical INC. are subject to a Lock-Up Agreement Ending on 1-JUL-2022. CI
Qingdao Baheal Medical to List 12.5% Stake Post IPO Lock-Up MT
Qingdao Baheal Medical INC. Announces Final Dividend on A Shares for the Year 2021, Payable on May 25, 2022 CI
Qingdao Baheal Medical Inc. Approves Dividend for 2021 CI
Qingdao Baheal Medical INC. Announces Final Cash Dividend Proposal for 2021 CI
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Qingdao Baheal Medical to List 2.9 Million Shares Post IPO Lockup Period MT
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Qingdao Baheal Medical INC. has completed an IPO in the amount of CNY 401.864 million. CI
Qingdao Baheal Medical INC. has filed an IPO. CI
Chart Qingdao Baheal Medical INC.
More charts
Qingdao Baheal Medical Inc is a China-based company mainly providing comprehensive marketing services for pharmaceutical product manufacturers. The Company provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The Company's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The Company mainly conducts its business within domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
32.42 CNY
Average target price
48 CNY
Spread / Average Target
+48.06%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301015 Stock
  4. News Qingdao Baheal Medical INC.
  5. Qingdao Baheal Medical to List 2.9 Million Shares Post IPO Lockup Period